Quick Search

 

 


 

 

Result Summary for 207499/040

Result Summary
Protocol ID: 207499/040
Clinical Study ID: 207499/040
Official Title: A Multicentre, Open-label Extension Study to Evaluate the Safety, Tolerability and Efficacy of Oral SB-207499 (15 mg twice daily) in Patients with Chronic Obstructive Pulmonary Disease (COPD).
Phase: Phase 3
Study Indications or Diseases:
  • Pulmonary Disease, Chronic Obstructive
Generic Name: cilomilast
Trade/Product Name: ariflo
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.